학술논문
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial
Document Type
Article
Author
Source
In The Lancet Oncology July 2011 12(7):673-680
Subject
Language
ISSN
1470-2045